{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T04:51:04Z","timestamp":1726030264484},"publisher-location":"New York, NY","reference-count":40,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493994496"},{"type":"electronic","value":"9781493994502"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9450-2_16","type":"book-chapter","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T04:02:32Z","timestamp":1559188952000},"page":"217-248","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant Poxviruses: Versatile Tools for Immunological Assays"],"prefix":"10.1007","author":[{"given":"Katherine S.","family":"Forsyth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Addison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence C.","family":"Eisenlohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"issue":"5986","key":"16_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/311578a0","volume":"311","author":"JR Bennink","year":"1984","unstructured":"Bennink JR, Yewdell JW, Smith GL, Moller C, Moss B (1984) Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature 311(5986):578\u2013579","journal-title":"Nature"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/smvy.1993.1005","volume":"4","author":"JW Yewdell","year":"1993","unstructured":"Yewdell JW, Anderson R, Cox JH, Eisenlohr LC, Esquivel F, Lapham C, Restifo NP, Bennink JR (1993) Multiple uses of viruses for studying antigen processing. Semin Virol 4:109\u2013116","journal-title":"Semin Virol"},{"issue":"4","key":"16_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.163.4.903","volume":"163","author":"LA Morrison","year":"1986","unstructured":"Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ (1986) Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med 163(4):903\u2013921","journal-title":"J Exp Med"},{"issue":"3","key":"16_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1084\/jem.172.3.947","volume":"172","author":"D Jaraquemada","year":"1990","unstructured":"Jaraquemada D, Marti M, Long EO (1990) An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J Exp Med 172(3):947\u2013954","journal-title":"J Exp Med"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.2047875","volume":"252","author":"B Moss","year":"1991","unstructured":"Moss B (1991) Vaccinia virus: a tool for research and vaccine development. Science 252:1662\u20131667","journal-title":"Science"},{"issue":"3","key":"16_CR6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/JVI.51.3.662-669.1984","volume":"51","author":"JP Weir","year":"1984","unstructured":"Weir JP, Moss B (1984) Regulation of expression and nucleotide sequence of a late vaccinia virus gene. J Virol 51(3):662\u2013669","journal-title":"J Virol"},{"issue":"4","key":"16_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0022-2836(89)90108-3","volume":"210","author":"AJ Davison","year":"1989","unstructured":"Davison AJ, Moss B (1989) Structure of vaccinia virus late promoters. J Mol Biol 210(4):771\u2013784","journal-title":"J Mol Biol"},{"issue":"4","key":"16_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0022-2836(89)90107-1","volume":"210","author":"AJ Davison","year":"1989","unstructured":"Davison AJ, Moss B (1989) Structure of vaccinia virus early promoters. J Mol Biol 210(4):749\u2013769","journal-title":"J Mol Biol"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1146\/annurev.bi.59.070190.003305","volume":"59","author":"B Moss","year":"1990","unstructured":"Moss B (1990) Regulation of vaccinia virus transcription. Annu Rev Biochem 59:661\u2013688","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"16_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/viro.1997.8845","volume":"238","author":"MW Carroll","year":"1997","unstructured":"Carroll MW, Moss B (1997) Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238(2):198\u2013211","journal-title":"Virology"},{"issue":"1","key":"16_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","volume":"55","author":"E Clercq De","year":"2002","unstructured":"De Clercq E (2002) Cidofovir in the treatment of poxvirus infections. Antivir Res 55(1):1\u201313","journal-title":"Antivir Res"},{"issue":"7","key":"16_CR12","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1128\/JVI.67.7.4323-4336.1993","volume":"67","author":"JA Taddie","year":"1993","unstructured":"Taddie JA, Traktman P (1993) Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3\u2032\u20135\u2032 exonuclease domain. J Virol 67(7):4323\u20134336","journal-title":"J Virol"},{"key":"16_CR13","volume-title":"Jenner\u2019s smallpox vaccine. the riddle of the origin of vaccinia virus","author":"D Baxby","year":"1981","unstructured":"Baxby D (1981) Jenner\u2019s smallpox vaccine. the riddle of the origin of vaccinia virus. Heinemann, London"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","volume":"86","author":"DJ Esteban","year":"2005","unstructured":"Esteban DJ, Buller RM (2005) Ectromelia virus: the causative agent of mousepox. J Gen Virol 86. (Pt 10:2645\u20132659","journal-title":"J Gen Virol"},{"issue":"4","key":"16_CR15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.63.4.341","volume":"63","author":"F Fenner","year":"1949","unstructured":"Fenner F (1949) Mouse-pox; infectious ectromelia of mice; a review. J Immunol 63(4):341\u2013373","journal-title":"J Immunol"},{"issue":"3","key":"16_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","volume":"75","author":"RJ Jackson","year":"2001","unstructured":"Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA (2001) Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 75(3):1205\u20131210","journal-title":"J Virol"},{"issue":"15","key":"16_CR17","first-page":"401","volume":"57","author":"CDC","year":"2008","unstructured":"CDC (2008) Laboratory-acquired vaccinia exposures and infections\u2014United States, 2005\u20132007. MMWR Morb Mortal Wkly Rep 57(15):401\u2013404","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6040","key":"16_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/317813a0","volume":"317","author":"RM Buller","year":"1985","unstructured":"Buller RM, Smith GL, Cremer K, Notkins AL, Moss B (1985) Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317(6040):813\u2013815","journal-title":"Nature"},{"issue":"7","key":"16_CR19","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.66.7.4170-4179.1992","volume":"66","author":"R Blasco","year":"1992","unstructured":"Blasco R, Moss B (1992) Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J Virol 66(7):4170\u20134179","journal-title":"J Virol"},{"issue":"16","key":"16_CR20","doi-asserted-by":"publisher","first-page":"7528","DOI":"10.1128\/JVI.75.16.7528-7542.2001","volume":"75","author":"M Husain","year":"2001","unstructured":"Husain M, Moss B (2001) Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles. J Virol 75(16):7528\u20137542","journal-title":"J Virol"},{"issue":"2","key":"16_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","volume":"158","author":"R Blasco","year":"1995","unstructured":"Blasco R, Moss B (1995) Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158(2):157\u2013162","journal-title":"Gene"},{"key":"16_CR22","first-page":"15","volume":"269","author":"MM Lorenzo","year":"1995","unstructured":"Lorenzo MM, Galindo I, Blasco R (1995) Construction and isolation of recombinant vaccinia virus using genetic markers. Methods Mol Bio 269:15\u201330","journal-title":"Methods Mol Bio"},{"key":"16_CR23","volume-title":"Purification of vaccinia virus","author":"PL Earl","year":"1993","unstructured":"Earl PL, Moss B (1993) Purification of vaccinia virus. Greene and Wiley-Interscience, New York, NY"},{"issue":"24","key":"16_CR24","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1128\/JVI.01732-12","volume":"86","author":"F Roscoe","year":"2012","unstructured":"Roscoe F, Xu R, Sigal LJ (2012) Characterization of Ectromelia virus deficient in EMV036, the homolog of vaccinia virus F13L, and its application for the rapid generation of recombinant viruses. J Virol 86(24):13501\u201313507","journal-title":"J Virol"},{"issue":"5","key":"16_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2144\/000112012","volume":"39","author":"JM S\u00e1nchez-Puig","year":"2005","unstructured":"S\u00e1nchez-Puig JM, Blasco R (2005) Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker. BioTechniques 39(5):665\u2013670","journal-title":"BioTechniques"},{"issue":"11","key":"16_CR26","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3685::AID-IMMU3685>3.0.CO;2-3","volume":"28","author":"I Motta","year":"1998","unstructured":"Motta I, Lone YC, Kourilsky P (1998) In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR\/ligand density. Eur J Immunol 28(11):3685\u20133695","journal-title":"Eur J Immunol"},{"issue":"2","key":"16_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","volume":"8","author":"K Murali-Krishna","year":"1998","unstructured":"Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8(2):177\u2013187","journal-title":"Immunity"},{"issue":"5284","key":"16_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284):94\u201396","journal-title":"Science"},{"issue":"7","key":"16_CR29","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.4049\/jimmunol.163.7.3735","volume":"163","author":"EJ Wherry","year":"1999","unstructured":"Wherry EJ, Puorro KA, Porgador A, Eisenlohr LC (1999) The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J Immunol 163(7):3735\u20133745","journal-title":"J Immunol"},{"issue":"1","key":"16_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4049\/jimmunol.156.1.153","volume":"156","author":"NS Williams","year":"1996","unstructured":"Williams NS, Engelhard VH (1996) Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. J Immunol 156(1):153\u2013159","journal-title":"J Immunol"},{"issue":"25","key":"16_CR31","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1073\/pnas.1202143109","volume":"109","author":"M Fang","year":"2012","unstructured":"Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, Ma X et al (2012) Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection. Proc Natl Acad Sci U S A 109(25):9983\u20139988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"16_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/intimm\/6.3.369","volume":"6","author":"S Sanderson","year":"1994","unstructured":"Sanderson S, Shastri N (1994) LacZ inducible, antigen\/MHC-specific T cell hybrids. Int Immunol 6(3):369\u2013376","journal-title":"Int Immunol"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1073\/pnas.89.13.6020","volume":"89","author":"J Karttunen","year":"1992","unstructured":"Karttunen J, Sanderson S, Shastri N (1992) Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T cell antigens. Proc Natl Acad Sci 89:6020\u20136024","journal-title":"Proc Natl Acad Sci"},{"issue":"4908","key":"16_CR34","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1126\/science.2471266","volume":"244","author":"JW Yewdell","year":"1989","unstructured":"Yewdell JW, Bennink JR (1989) Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244(4908):1072\u20131075","journal-title":"Science"},{"issue":"9","key":"16_CR35","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.4049\/jimmunol.168.9.4455","volume":"168","author":"EJ Wherry","year":"2002","unstructured":"Wherry EJ, McElhaugh MJ, Eisenlohr LC (2002) Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope. J Immunol 168(9):4455\u20134461","journal-title":"J Immunol"},{"issue":"9","key":"16_CR36","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","volume":"187","author":"A Gallimore","year":"1998","unstructured":"Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, Zinkernagel R (1998) Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 187(9):1383\u20131393","journal-title":"J Exp Med"},{"issue":"12","key":"16_CR37","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188(12):2205\u20132213","journal-title":"J Exp Med"},{"issue":"4","key":"16_CR38","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V86.4.1408.bloodjournal8641408","volume":"86","author":"LJ Picker","year":"1995","unstructured":"Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory\/effector T cells by flow cytometry. Blood 86(4):1408\u20131419","journal-title":"Blood"},{"issue":"1","key":"16_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1084\/jem.168.1.293","volume":"168","author":"Y Jin","year":"1988","unstructured":"Jin Y, Shih WK, Berkower I (1988) Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J Exp Med 168(1):293\u2013306","journal-title":"J Exp Med"},{"issue":"1","key":"16_CR40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.70.1.165-171.1996","volume":"70","author":"K Tsung","year":"1996","unstructured":"Tsung K, Yim JH, Marti W, Buller RM, Norton JA (1996) Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol 70(1):165\u2013171","journal-title":"J Virol"}],"container-title":["Methods in Molecular Biology","Antigen Processing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9450-2_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T21:24:38Z","timestamp":1694899478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9450-2_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493994496","9781493994502"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9450-2_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"31 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}